This inventor holds 1 USPTO granted patent. Top assignees: Delta Electronics, Inc., National Central University, Other. Active years: 2021.
Company Filing History:
1 out of 3,528 
1 out of 423 
1 out of 834,453 Years Active: 2021
Title: Chao-Hsiang Chang: Innovator in Urothelial Carcinoma Detection
Introduction
Chao-Hsiang Chang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of urothelial carcinoma. His innovative approach has the potential to enhance early detection and treatment options for patients.
Latest Patents
Chao-Hsiang Chang holds a patent for a method aimed at treating urothelial carcinoma. The patent describes a kit for detecting urothelial carcinoma, which includes at least one primer or probe for identifying specific miRNAs. The miRNAs included in the kit are selected from a group consisting of miR-19b-1, miR-636, miR-150, miR-155, miR-183, miR-378, miR-210, miR-487, and combinations thereof. Additionally, the method involves detecting the expression levels of these miRNAs in a sample from a subject.
Career Highlights
Throughout his career, Chao-Hsiang Chang has worked at National Central University, where he has contributed to research and development in the field of medical diagnostics. His work has been instrumental in advancing the understanding of urothelial carcinoma and improving detection methods.
Collaborations
Chao-Hsiang Chang has collaborated with notable colleagues, including Chen-Huan Lin and An-Lun Li. These partnerships have fostered innovation and have been crucial in the development of his patented methods.
Conclusion
Chao-Hsiang Chang's contributions to the detection of urothelial carcinoma exemplify the impact of innovative thinking in medical science. His work not only advances diagnostic techniques but also holds promise for improving patient outcomes.